We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CorMedix Inc | NASDAQ:CRMD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.46 | 8.57% | 5.83 | 5.78 | 8.48 | 5.92 | 5.4305 | 5.49 | 1,028,713 | 05:00:04 |
1. Name and Address of Reporting Person * Kaplan Myron | 2. Issuer Name and Ticker or Trading Symbol CorMedix Inc. [ CRMD ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 5/17/2021 | P | 15000 | A | $6.0318 (1) | 165034 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (Right to Buy Common Stock) | $8.32 | (2) | 1/11/2031 | Common Stock | 30000 | 30000 | D | ||||||||
Stock Option (Right to Buy Common Stock) | $5.63 | (3) | 2/25/2030 | Common Stock | 15000 | 15000 | D | ||||||||
Stock Option (Right to Buy Common Stock) | $8.3 | (4) | 1/10/2029 | Common Stock | 15000 | 15000 | D | ||||||||
Stock Option (Right to Buy Common Stock) | $2.85 | (5) | 2/16/2028 | Common Stock | 8000 | 8000 | D | ||||||||
Stock Option (Right to Buy Common Stock) | $11.2 | (6) | 2/21/2027 | Common Stock | 8000 | 8000 | D | ||||||||
Stock Option (Right to Buy Common Stock) | $21.4 | (7) | 4/28/2026 | Common Stock | 10000 | 10000 | D |
Remarks: The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Kaplan Myron C/O CORMEDIX INC., 300 CONNELL DRIVE, SUITE 4200 BERKELEY HEIGHTS, NJ 07922 | X |
Signatures | ||
/s/ Myron Kaplan | 5/19/2021 | |
**Signature of Reporting Person | Date |
1 Year CorMedix Chart |
1 Month CorMedix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions